Podcasts about Chorus

We're talking about the entry of a bona fide progressive into the DC mayor's race, Donald Trump's plans for Dulles Airport, and the return of stars to the Washington Post's restaurant reviews. In a members only 4th segment, what's going on with ranked choice voting in DC? Want some more DC news? Then make sure to sign up for our morning newsletter Hey DC. You can text us or leave a voicemail at: (202) 642-2654. You can also become a member, with ad-free listening, for as little as $10 a month. Learn more about the sponsors of this December 5th episode: Nace Law Group Gay Men's Chorus of Washington, DC Public Welfare Foundation St. Ann's Center for Children, Youth and Families

For a lot of people in DC, the name “Saint Elizabeth's” still conjures the likes of John Hinckley. But the sprawling campus that housed what used to be known as an insane asylum has transformed over the past two decades, with the hospital's footprint shrinking and a lot of new stuff coming in: A cabinet department, a basketball arena, some pretty-looking housing. And according to the Washington Business Journal's Michael Neibauer, more is on the way. Here's what you need to know. Want some more DC news? Then make sure to sign up for our morning newsletter Hey DC. You can also become a member, with ad-free listening, for as little as $10 a month. Learn more about the sponsors of this December 4th episode: Nace Law Group Gay Men's Chorus of Washington, DC St. Ann's Center for Children, Youth and Families Interested in advertising with City Cast? Find more info HERE.

Join City Cast DC co-host Bridget Todd alongside fellow hosts from Austin, Chicago, Denver, Las Vegas, Madison, Nashville, Philly, Pittsburgh, Portland, Salt Lake, Seattle, and the Twin Cities for a special episode that'll help you knock out your holiday shopping early and support small businesses around the country. From a handlebar mount (and app!) that'll turn your phone into a bike cam, to a mustard-of-the-month subscription box, our hosts are here to tell the stories of local businesses in their cities making cool stuff that you can order online right now. Visit our website to find the full list of recommendations with links for holiday shopping! Want some more DC news? Then make sure to sign up for our morning newsletter Hey DC. You can text us or leave a voicemail at: (202) 642-2654. You can also become a member, with ad-free listening, for as little as $10 a month. Learn more about the sponsors of this December 3rd episode: Nace Law Group Gay Men's Chorus of Washington, DC St. Ann's Center for Children, Youth and Families Interested in advertising with City Cast? Find more info HERE.

After the tragic attack on two National Guard members that left one of them dead and the other fighting for his life in the hospital, the Trump administration quickly announced plans to put 500 additional National Guard troops on DC's streets, this time with DC police accompanying them for protection. All of this while there are still many unanswered questions about what exactly happened in this attack. The Washington Post's Olivia George joins to tell us what we DO know. Want some more DC news? Then make sure to sign up for our morning newsletter Hey DC. You can text us or leave a voicemail at: (202) 642-2654. You can also become a member, with ad-free listening, for as little as $10 a month. Learn more about the sponsors of this December 2nd episode: Nace Law Group Gay Men's Chorus of Washington, DC St. Ann's Center for Children, Youth and Families Interested in advertising with City Cast? Find more info HERE.

Schrijver en journalist Jutta Chorus groeide op met verhalen over haar grootvader Leen Menken, een boerenzoon die zich opwerkte tot succesvol melkhandelaar. Dagen van melk volgt Chorus' familieverhaal en de op- en ondergang van het familiebedrijf. Maar het is ook een verhaal over klasse, ambitie, en de ongemakkelijke erfenissen van vooruitgang.Programmamakker Katarina Schul gaat in gesprek met Jutta Chorus. Hoe verhoud je je als journalist tot je eigen familiegeschiedenis? Hoe dicht mag je bij je personages komen, als zij je ooms, tantes of grootvader zijn? En hoe verandert een archiefstuk als je het tot een literaire scène maakt met een dialoog, personageopbouw en cliffhanger?Plein Publiek is een reeks verdiepende interviews met toonaangevende makers, geselecteerd door onze eigen programmamakers. Verwacht intieme gesprekken met uitzonderlijke stemmen die je aan het denken zetten.Zie het privacybeleid op https://art19.com/privacy en de privacyverklaring van Californië op https://art19.com/privacy#do-not-sell-my-info.

Moodie Cheikh, CEO and founder of Searidge Technologies discuss the company latest projects in Doha and how a hybrid digital tower allows air traffic controllers manage new parts of the airport where direct visibility is restricted.The discussion also covers wider topics:the company's history, as it approaches its 20th anniversaryfactors behind a success in different contexts, like the Middle East, North America, UK, Hong Kong, and Singaporehow software platforms should be the standard and what Searidge's Chorus platform allowsMoodie's view on interoperability, and a honest and optimistic opinion about what the industry should do nextthe integration of artificial intelligence in air traffic controlFor this very technical episode, we revisit our previous signature question about the future of ATM in 5 and 50 years - before asking the new one too.

Whether you're a holiday grump or can't get enough of all things merry and bright, we've got your guide to what to eat, drink, see, and do this December in DC, from Guinness World Record kissing to DC's best gifts. If you're new here, welcome! We've put together a starter pack for you, with episodes and articles to welcome you to the City Cast community. For even more tips on how to make the most of November in DC, check out Hey DC's take on what to do this month.  If you enjoyed today's interview with District Bridges' Director of Storytelling and Marketing, Anna Claire, learn more here. Learn more about the sponsors of this December 1st episode: Nace Law Group Gay Men's Chorus of Washington, DC St. Ann's Center for Children, Youth and Families Interested in advertising with City Cast? Find more info HERE. Reach us at DC@citycast.fm.

A small New England college nestled in the Green Mountains during snowfall, ambience. It's the holidays, 1968; the chorus of Norwich University and Vermont College readies for their performance of Winter Songs. And you are invited. Well somewhat invited — obviously the 60's are long gone, man. And the perspective for this performance will play outside of Plumley Armory pattering with falling snow.Passing traffic on snowy South Main — yes I'm being an ****** on purpose it's Christmas — into charming (blue collar AF and I say that with admiration) Northfield, Vermont.  I hope everyone enjoys the holidays this year, whether you celebrate or not. Seriously, enjoy the holidays; now go away. I don't want to give up too much on how the sausage is made for the folks who just read a few lines and bounce. Just a couple more sentences and those people will disappear. What did y'all think of the Steam cube? OK, I feel like we've shaken off the normies — I found an obscure vinyl recording of a 1968 choral performance (no background sounds those were added) by Norwich University and Vermont College. I'm not entirely sure what part of the year this recording coincided. With several invocations of the Devine I assumed the original recording must be Christmas. And I definitely wanted to imagine there was snow coming down for this performance (which could have been Spring, it snows like hell some Springs up there). I'm positive divinity and salvation were pretty evergreen in 1968 for military college students on the precipice of graduation and probably the Vietnam War soon after.I have to think more than one voice in this recording will be silenced by that war. Not to dampen spirits, I think we could hold on to that in a world ravaged by basic human instincts. There's a lot of “that” to hold on to this holiday season. Maybe that's why we sing?

Sunday December 7, 2025 at First United Methodist Church 3:00 pm "Illuminare"

A special bonus episode to share my interview with Cliff Norris and David Aurilio to learn about the histories of the Atlanta Freedom Bands, a nonprofit community music organization made up of LGBTQ+ musicians and allies that includes a full concert band, marching band, jazz ensemble, and several small groups, and Voices of Note, the nonprofit organization that oversees Atlanta's LGBTQ+ choral groups, including the Atlanta Gay Men's Chorus and the Atlanta Women's Chorus. We covered the history of how these groups formed in Atlanta, why they were needed and how they fared through the AIDS crisis. In the upcoming weeks, each group has several concerts, including the one that I am hosting on December 20th!  Events: Holidays on Peachtree Street Atlanta Gay Men's Chorus Atlanta Women's Chorus Other Links: www.voicesofnote.org  www.atlantafreedombands.com  www.oursongatlanta.org  www.outfronttheatre.com  www.outonfilm.org  www.atlantaphilharmonic.org  www.southernfriedqueerpride.com - 

This week, Kate Molleson explores the life and work of a musical giant – drummer and composer Max Roach – in the company of writer and broadcaster Kevin Le Gendre. Together they trace Roach's extraordinary journey: from his early days at the heart of bebop alongside Bud Powell, Thelonious Monk, Dizzy Gillespie and Charlie Parker, through his pioneering role as a bandleader, his political activism during the civil rights era, and his later innovations in percussion and collaboration. Roach's story is one of constant reinvention as performer, composer and activist, shaping jazz and beyond for more than half a century.Music includes: Dr Free-Zee (from Max Roach +4) Joy Spring (from Clifford Brown and Max Roach) Bu Dee Daht (from Coleman Hawkins: Rainbow Mist) Salt Peanuts (from Dizzy Gillespie and Charlie Parker: Town Hall, New York City, June 22, 1945) Ko-Ko (from Charlie Parker: The Complete Savoy and Dial Master Takes) Bird Gets the Worm (from Charlie Parker: The Complete Savoy and Dial Master Takes) Move (from Miles Davis: The Complete Birth of the Cool) Cherokee (from Jazz at Massey Hall) Cou Manchi-Cou (from Max Roach Quartet, featuring Hank Mobley) Maximum (from In the Beginning) Daahoud (from Clifford Brown and Max Roach) Sandu (from Study in Brown) Take the A Train (from Study in Brown) Fleurette Africain (from Money Jungle) Driva'man (from We Insist! Max Roach's Freedom Now Suite) Freedom Day (from We Insist! Max Roach's Freedom Now Suite) Garvey's Ghost (from Percussion Bitter Sweet) Lonesome Lover (from It's Time: Max Roach, his Chorus and Orchestra) The Drum Also Waltzes (from Drums Unlimited) Libra (from Members Don't Git Weary) Let Thy People Go (from Lift Every Voice and Sing) Joshua (from Lift Every Voice and Sing) A Quiet Place (from Collage) Double Delight (from Bright Moments) Spirit Possession (from Birth and Rebirth) Love is a Many Splendored Thing (from Clifford Brown and Max Roach at Basin Street) Presented by Kate Molleson. Produced by Martin Williams for BBC Audio Wales & West. For full track listings, including artist and recording details, and to listen to the pieces featured in full (for 30 days after broadcast) head to the series page for Max Roach (1924-2007) https://www.bbc.co.uk/programmes/m002mb7w. And you can delve into the A-Z of all the composers we've featured on Composer of the Week here: http://www.bbc.co.uk/programmes/articles/3cjHdZlXwL7W41XGB77X3S0/composers-a-to-z.

In the first half of this episode, Patrick and Tommie are joined by John J. Steele, Jr., who discusses the upcoming concerts of the Long Island Gay Men's Chorus and his directing of a local production of The Lion In Winter. The men learn about wolf DNA in dogs, meet the Saint-Usuge Spaniel, celebrate the birthdays of two gay icons and the king of the nerds, say farewell to gay German actor Udo Kier and reggae singer Jimmy Cliff, take a trip to Casablanca, learn about the 1977 broadcast interruption from the Ashtar Galactic Command, and listen to the jukebox while debating whether cheesecake is an actual cake. (Part Two will be released on December 3.)

"The The Office of the US Trade Representative has released their 2024 Piracy Report listing the notorious markets for counterfeiting and piracy. The practice is alive and well. This report dedicated an entire section just to music. We will tell you what it said."

Bookwaves/Artwaves is produced and hosted by Richard Wolinsky. Links to assorted local theater & book venues   Malcolm Margolin (1940-2025): Legendary Berkeley Publisher Malcolm Margolin (1940-2025), the long-time publisher of Heyday Books in Berkeley, who died on August 20, 2025 at the age of 84, in conversation with Richard Wolinsky in the KPFA Studios on November 21, 2014. Malcolm Margolin founded Heyday Books, the renownedy non-profit publishing house located in Berkeley, in 1974 and stayed until he retired in 2015. He was the author and editor of several books, most notably The Ohlone Way: Indian Life in the San Francisco – Monterey Bay Area, along with magazines and other periodicals. This interview was recorded November 21, 2014 upon the publication of his memoir/history, The Heyday of Malcolm Margolin: The Damned Good Times of a Fiercely Independent Publisher.  Malcolm Margolin retired in 2015 but continued to work until his death. His final book, Deep Hanging Out: Wanderings and Wonderment in Native California. was published by Heyday in 2021.   Azar Nafisi: Best-selling Author of “Reading Lolita in Tehran” Azar Nafisi,author of the best-selling memoir, “Reading Lolita in Tehran,”  in conversation with host Richard Wolinsky, recorded in the KPFA studios on January 12, 2009 while on tour for the memoir, “Things I've Been Silent About.” Azar Nafisi burst on the literary scene in 2003 with her memoir, Reading Lolita in Tehran in 2003, which remained on the New York Times best seller list for 117 weeks. Born in Tehran, Iran, she came to the United States in 1997 and became an American citizen in 2008. A professor of literature, she'd previously written a critical study of the works of Vladimir Nabokov. There would be a second interview with Azar Nafisi  in 2015 for her book about the importance of literature, The Republic of the Imagination. Azar Nafisi Wikipedia page     Book Interview/Events and Theatre Links Note: Shows may unexpectedly close early or be postponed due to actors' positive COVID tests. Check the venue for closures, ticket refunds, and mask requirements before arrival. Dates are in-theater performances unless otherwise noted. Some venues operate Tuesday – Sunday; others for shorter periods each week. All times Pacific Time. Closing dates are sometimes extended. Book Stores Bay Area Book Festival  See website for highlights from the 110th Annual Bay Area Book Festival, May 31 – June 1, 2025. Book Passage.  Monthly Calendar. Mix of on-line and in-store events. Books Inc.  Mix of on-line and in-store events. The Booksmith.  Monthly Event Calendar. BookShop West Portal. Monthly Event Calendar. Center for Literary Arts, San Jose. See website for Book Club guests in upcoming months. Green Apple Books. Events calendar. Kepler's Books  On-line Refresh the Page program listings. Live Theater Companies Actors Ensemble of Berkeley.  See website for readings and events. Actor's Reading Collective (ARC).  Mary Jane by Amy Herzog, directed by Amy Kossow, November 6 – 30, Magic Theatre, Fort Mason. African American Art & Culture Complex. See website for calendar. American Conservatory Theatre Judy Garland, We Need A Little Christmas with Debbie Wileman, Strand, Dec. 6-7. Rudolph & Scrooge, A YC Double Feature, December 18-20, Strand. A Streetcar Named Desire by Tennessee Williams, Jan. 21 – Feb. 1, 2026, Toni Rembe (Geary). Paranormal Activity, Feb. 19 – March 15, Toni Rembe. Awesome Theatre Company. See website for information. Berkeley Playhouse. Annie. November 7- December 21. Once, February 20 – March 22.  Berkeley Rep. The Hills of California .by Jez Butterworth, Oct. 31 – Dec. 7, Roda Theatre. Mother of Exiles by Jessica Huang, World Premiere, Nov. 14 – Dec. 21, Peets Theatre. Berkeley Shakespeare Company See website for upcoming productions. Brava Theatre Center: See calendar for events listings. BroadwaySF: The Golden Girls Live,  December 4-21, Curran. Moulin Rouge! The Musical, December 16-28, Orpheum. See website for complete listings for the Orpheum, Golden Gate and Curran Theaters. Broadway San Jose:  Kinky Boots, Nov. 28-30. See website for other events. Center REP: A Christmas Carol, Dec. 10 – 21.. Central Stage. See website for upcoming productions, 5221 Central Avenue, Richmond Central Works See website for information on the 2026 season. Cinnabar Theatre. Holiday Songbook, Dec. 19-21. My Fair Lady, January 23 – February 8, 2026. Club Fugazi. Dear San Francisco ongoing. Check website for Music Mondays listings. Contra Costa Civic Theatre Ebenezer Scrooge, an adaptation of “A Christmas Carol” by Joel Roster, December 6 –  21. . See website for other events. Golden Thread  See website for upcoming productions. Hillbarn Theatre: Rogers & Hammerstein's Cinderella, December 4 – 28. Lorraine Hansberry Theatre. Soulful Christmas, December 19-21, Magic Theatre. Los Altos Stage Company. A Christmas Carol, November  28 – December 21.. Lower Bottom Playaz  August Wilson's King Hedley II, November 8 -30. BAM House, Oakland. Magic Theatre. Actors Reading Collective: Mary Jane by Amy Herzog, directed by Amy Kossow, November 6 – 30, See website for other events and productions. Marin Shakespeare Company: See website for events and productions. Marin Theatre: The Gift of Nothing  by Patrick McDonnell, Aaron Posner and Erin Weaver, Dec. 13 – 23. .The Cherry Orchard by Anton Chekhov Jan . 29 – Feb. 22, 2026. Mission Cultural Center for Latino Arts Upcoming Events Page. New Conservatory Theatre Center (NCTC)  Ruthless,  Dec. 5 – January 11, 2026. New Performance Traditions.  See website for upcoming schedule Oakland Theater Project. Cabaret, November 21 – December 14. Odd Salon: Upcoming events in San Francisco & New York, and streaming. Palace of Fine Arts Theater.  See website for event listings. Pear Theater. Ada & The Engine  by Lauren Gunderson, November 21 – December 7. See website for staged readings and other events. Playful People Productions. See website for upcoming productions. Presidio Theatre. Peter Pan Panto, Nov. 29 – Dec. 28. See website for complete schedule of events and performances. Ray of Light: Mean Girls. May 2026. Ross Valley Players: See website for New Works Sunday night readings and other events. San Francisco Playhouse. Into the Woods. November 30 – January 17, 2026. SFBATCO.  See website for upcoming streaming and in- theater shows. San Jose Stage Company: See website for events and upcoming season Shotgun Players.  Sunday in the Park with George, November 15 – December 30. South Bay Musical Theatre:  Let It Snow: A Broadway Holiday Celebration, December 20-21, Little Women, The Broadway Musical, January 24 – February 14, 2026. SPARC: See website for upcoming events. Stagebridge: See website for events and productions. Storytime every 4th Saturday. The Breath Project. Streaming archive. The Marsh: Calendar listings for Berkeley, San Francisco and Marshstream. Theatre Lunatico  See website for upcoming productions.. Theatre Rhino  Pirates! by John Fisher, December 4 – 13. Streaming: Essential Services Project, conceived and performed by John Fisher, all weekly performances now available on demand. TheatreWorks Silicon Valley Georgiana & Kitty, Christmas at Pemberley by Lauren Gunderson and Margot Melcon, Dec. 3 – 28, Lucie Stern Theatre, Palo Alto. Word for Word.  See website for upcoming productions. Misc. Listings: BAMPFA: On View calendar for Berkeley Art Museum and Pacific Film Archive. Berkeley Symphony: See website for listings. Chamber Music San Francisco: Calendar, 2025 Season. Dance Mission Theatre. On stage events calendar. Fort Mason Center. Events calendar. Oregon Shakespeare Festival: Calendar listings and upcoming shows. San Francisco Gay Men's Chorus. See schedule for upcoming SFGMC performances. San Francisco Opera. Calendar listings. San Francisco Symphony. Calendar listings. Filmed Live Musicals: Searchable database of all filmed live musicals, podcast, blog. If you'd like to add your bookstore or theater venue to this list, please write Richard@kpfa.org   . The post Bookwaves/Artwaves – November 27, 2025: Malcolm Margolin – Azar Nafisi appeared first on KPFA.

“Going into high school, I did everything possible to avoid the performing arts. My vice principal called me into the office and said, ‘you can't have an open period. I'm gonig to put you in choir.' Within weeks, it became a life-changing experience for me – I discovered a community, a way to express myself. I knew by the end of my junior year in high school that this is what I wanted to do.” - Brandon Elliott“If you are coming as a conductor to composing, you already have a resource that a lot of composers lack. You know what your singers need. You have already identified a lack in the repertoire that you're looking for, something that you might fill as a composer. If you can get into that mindset with your own ensemble, you'll be so ready, so prepared to take that on for other groups.” - Dale TrumboreDale Trumbore is a Los Angeles-based composer and writer whose music has been called “devastatingly beautiful” (The Washington Post) and praised for its “soaring melodies and beguiling harmonies deployed with finesse” (The New York Times). Trumbore's compositions have been performed widely in the U.S. and internationally by Atlanta Master Chorale, the Chicago Symphony's MusicNOW ensemble, Conspirare and the Miró Quartet, Los Angeles Children's Chorus, Los Angeles Master Chorale, National Youth Choir of Scotland, Pasadena Symphony, Phoenix Chorale, and Seraphic Fire.Trumbore is the recipient of ACDA's inaugural Raymond W. Brock Competition for Professional Composers, an ASCAP Morton Gould Award, and a Chamber Music America Classical Commissioning Grant. She has written extensively about working through creative blocks and establishing a career in music in essays and in two books, Composing a Living (cowritten with Brandon Elliott) and Staying Composed. Learn more about Trumbore's music and writing at daletrumbore.com.Dr. Brandon Elliott is a conductor, educator, and consultant specializing in creative and strategic leadership in the arts and entertainment industry. He is a Professor of Music at Saddleback College and Founder & Artistic Director of Choral Arts Initiative, an award-winning ensemble dedicated to contemporary choral music. A sought-after consultant and Fulbright Specialist, he advises on artist management, organizational change, career development, and the evolving music industry.To get in touch with Dale, you can visit her website, daletrumbore.com, where you can also sign up for her newsletter. To get in touch with Brandon, visit his website, brandon-elliott.com, which also provides links to his social media accounts.Email choirfampodcast@gmail.com to contact our hosts.Podcast music from Podcast.coPhoto in episode artwork by Trace Hudson

In this special two-part Thanksgiving bonus episode, Blake and Jack take listeners on a fast-moving, 30,000-foot flyover of the wild, chaotic, and faith-shaping events that led to the Pilgrims boarding the Mayflower and eventually celebrating what we call the First Thanksgiving. Before the Mayflower ever touched the shores of the New World, England endured a century of political turmoil, religious reform, royal power struggles, public executions, and theological awakening. From Henry VIII's messy pursuit of an annulment, to Edward VI's Protestant reforms, to the brutal burnings under Bloody Mary, to Elizabeth's uneasy religious compromise, and finally to King James and his push for conformity—this episode explores the real forces that shaped the Puritans and the Separatists, and ultimately birthed the Pilgrim story. This episode aims to help you see Thanksgiving with fresh eyes and a deeper appreciation for the believers who risked everything to pursue biblical worship.   Connect Website & Blog: www.chorusinthechaos.com Facebook: https://www.facebook.com/chorusinthec... Instagram: https://www.instagram.com/chorus_in_the_chaos/ Twitter: https://twitter.com/Chorusnthechaos Intro/Outro Music (by our good friend Nick Illes): https://open.spotify.com/artist/7tnsQ... Email: chorusinthechaos@email.com Generations Be sure to visit our friends at Generations.org! They've built an incredible library of Christ-centered homeschool curriculum, books, and podcasts — all designed to help your family apply the Bible to every area of life. History, science, worldview, you name it — it all points back to Christ. Use the code CHORUS at checkout for 15% off your order.

In Part 2 of our Thanksgiving bonus series, Blake and Jack pick up the story with the Pilgrims themselves—the Separatist congregation from Scrooby who fled England, suffered betrayals, survived storms, endured heartbreak, and ultimately crossed the Atlantic in one of history's most remarkable journeys of faith. In this episode, we trace their escape attempts from England, their difficult 11-year stay in Leiden, the economic and cultural pressures they faced, and the providential chain of events that drove them to sail for the New World, from the disastrous Speedwell, to the treacherous Mayflower crossing, to the first contacts with the Wampanoag, Squanto's astonishing backstory, the devastating first winter, and finally the feast that would one day inspire Thanksgiving....including a totally true and not dramatized version of how Turkey got involved. If you want to understand Thanksgiving—not the simplified version you learned in elementary school, but the providential and theologically rich version—this episode is for you. Connect Website & Blog: www.chorusinthechaos.com Facebook: https://www.facebook.com/chorusinthec... Instagram: https://www.instagram.com/chorus_in_the_chaos/ Twitter: https://twitter.com/Chorusnthechaos Intro/Outro Music (by our good friend Nick Illes): https://open.spotify.com/artist/7tnsQ... Email: chorusinthechaos@email.com Generations Be sure to visit our friends at Generations.org! They've built an incredible library of Christ-centered homeschool curriculum, books, and podcasts — all designed to help your family apply the Bible to every area of life. History, science, worldview, you name it — it all points back to Christ. Use the code CHORUS at checkout for 15% off your order.

The Chicago Gay Men's Chorus (CGMC) has been entertaining audiences year-round for over 40 years. But it's also a place of community, warmth and acceptance for those “in” the show and those watching it from the audience. This Christmas, CGMC presents “Holly Dolly Christmas” – a Holiday Tribue to the legendary Dolly Parton. Nearly 250 singers and […]

Ouri's latest album, Daisy Cutter, is a release of control, an excavation of inner truths, & an indulgence of sensuality. As always, we dive into the record's themes in depth, & we make sure to nerd out about Imogen Heap & FKA twigs along the way. Find Ouri on Spotify: https://open.spotify.com/artist/41gxyJbzbAaChEyrZ9j3rv?si=RCBJvcV6TeKATOOYCHIB1g On Apple Music: https://music.apple.com/us/artist/ouri/584625515 Instagram: https://www.instagram.com/ouri.riou/?hl=en Subscribe: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://beforethechorus.bio.to/listen⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Sign up for our newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.beforethechorus.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@beforethechoruspodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@soundslikesofia⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ About the podcast: Welcome to Before the Chorus, where we go beyond the sounds of our favourite songs to hear the stories of the artists who wrote them. Before a song is released, a record is produced, or a chorus is written, the musicians that write them think. A lot. They live. A lot. And they feel. A LOT. Hosted by award-winning interviewer Sofia Loporcaro, Before the Chorus explores the genuine human experiences behind the music. Sofia's deep knowledge of music and personal journey with mental health help her connect with artists on a meaningful level. This is a space where fans connect with artists, and listeners from all walks of life feel seen through the stories that shape the music we love. About the host: Sofia Loporcaro is an award-winning interviewer and radio host who's spent over 8 years helping musicians share their stories. She's hosted shows for Amazing Radio, and Transmission Roundhouse. Now on Before the Chorus, she's had the chance to host guests like Glass Animals, Feist, Madison Cunningham, Mick Jenkins, & Ru Paul's Drag Race winner Shea Couleé. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us a textMessiah Chorus of Lake County 2012 64th Presentation disk 1 ("And the Glory" Chorus starts at 22:02)Messiah Chorus of Lake County 2012 64th Presentation disk 2("Hallelujah" Chorus is at 41:19)Home (Messiah Chorus of Lake County home page)

Don't you sweat it, baby! It's alright… Sara and Laura are dancing through each verse of Opalite in today's episode. As one of The Life Of A Showgirl's most upbeat and happy-go-lucky songs, the ladies have made soooo many connections to Taylor's past albums tucked away in its lyrics. Enjoy this joy-filled episode! Chapters(00:00) Welcome!(00:41) What's On Our Plates(16:22) Taylor Updates(25:33) Analyzing "Opalite"(28:36) Personal Connections to the Song(32:27) Folk"lore" Of the Song(37:04) Verse 1: Callbacks To Exes, Austin Shoutout!, Ghosts, Lana Del Rey(45:24) Pre Chorus 1: Mistakes Made, Wrong Relationships(50:46) Chorus 1: Lightning Metaphors, Andrea's Advice(58:24) Verse 2: Some Shade, She Left The Restaurant!, Life's Lessons In Moving On(01:06:54) Pre Chorus 2: Moving On, Pep Talk(01:09:02) Chorus 2: Made To Be(01:10:14) Bridge: Navigating The Storm Together, Finding Shelter In Each Other, Thunder Metaphor(01:18:28) Music Theory Analysis: 60's Influences, Bridge Build, The Ronettes(01:19:48) Favorite Lyrics and Rating(01:22:34) This Song As A Recipe(01:24:45) Signing Off!(01:26:10) Patreon Preview: Would've, Could've, Should'veSUPPORT US ON PATREON! Show us some love and get monthly bonus episodes and first dibs on upcoming episode ideas. We'd be enchanted to have you join our Swiftie community!Links ReferencedCoconut Meringue Macaroons RecipeAngel Food Cake With Strawberries & Whipped Cream RecipePlease make sure to subscribe and leave a review. If you'd like to reach out to send in a question or comment, please do so via any of these platforms:email blankplatepod@gmail.comleave a voicemail at (717) 382-831Patreon (get bonus episodes and first dibs on episode ideas)YouTubeInstagramTikTokYou can also follow Sara and Laura individually:• Laura: Instagram and Tiktok• Sara: InstagramListen to our previous podcast: Passports & Pizza

MUSICBack in March, Billy Corgan announced that he would celebrate the 30th anniversary of The Smashing Pumpkins' third album, 1995's Mellon Collie and the Infinite Sadness, with a seven-night run at the Lyric Opera of Chicago. Billed as A Night of Mellon Collie and Infinite Sadness, the first of the seven nights is this Friday and it features Corgan and a group of guest artists backed by the Lyric Opera of Chicago Orchestra and Chorus performing orchestral and operatic versions of the 28 songs from the double album. Tom Morello has bad news for Audioslave fans. He says the surviving members are "no closer" to releasing unheard material featuring late singer Chris Cornell. https://ultimateclassicrock.com/tom-morello-audioslave-unheard-material/ Zach Bryan just posted a long message on Instagram saying that he's been sober for almost two months. He told fans this isn't some "greater than thou sentiment," and he knows he is lucky, but he wanted to speak up because so many people struggle in silence. Zach said a long motorcycle trip across the country helped him see he "really needed" support. https://www.usatoday.com/story/entertainment/music/2025/11/19/zach-bryan-health-sobriety-essay/87351087007/ · San Francisco's iconic rock spot, The Phoenix Hotel, which welcomed everyone from Neil Young to David Bowie and Kurt Cobain, is closing its doors for good after four decades this January.https://ultimateclassicrock.com/phoenix-san-francisco-rock-star-hotel-closing/ MOVING ON INTO MOVIE NEWS:"Wicked: For Good" hits theaters tomorrow. If you haven't already caught an early screening, there are five key scenes in "The Wizard of Oz" you might want to revisit. https://people.com/wizard-of-oz-scenes-watch-before-wicked-for-good-11852342 Kevin Spacey says his current financial situation isn't great, and he's homeless. He lives in hotels and Airbnbs as he "goes where the work is." A sequel to "The Family Stone" is in the works. Thomas Bezucha, who directed the 2005 holiday classic, had been working on a follow-up since before Keaton's death. https://people.com/family-stone-sequel-in-the-works-honor-diane-keaton-after-death-11852936 BODY TALK:They don't call him The Shat for nothing. William Shatner once pooped his pants during a Broadway show, and it wasn't that long ago. https://youtu.be/NcigPUrSb74 Olivia Munn had a really bad experience involving sushi, a bathtub, and her stomach, as she explained on the "Today" show. https://ew.com/olivia-munn-projectile-vomited-in-airport-after-eating-sushi-in-bath-11852930· AND FINALLYThe Billboard staff has compiled its list of "The 50 Best Rock Bands." https://www.billboard.com/lists/best-rock-bands/50-red-hot-chili-peppers/ AND THAT IS YOUR CRAP ON CELEBRITIES!Follow The Rizzuto Show @rizzshow on social media for more from your favorite daily comedy show. Connect with The Rizzuto Show online at 1057thepoint.com/RizzShow. Heard daily on the radio at 105.7 The Point in St. Louis, MO.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most new account executives stare at their territory list and feel the weight of it immediately. Fifty accounts. A hundred accounts. Sometimes more. Each one needs research, a plan, and outreach that doesn't sound like every other cold email clogging their prospect's inbox.  Jake McOsker, an account executive at Forrester Research, found himself facing exactly this problem when he moved from BDR to AE. He cracked it by changing how he used AI for account planning.  "Rather than taking 10 to 15 minutes to get an account plan out or understand who the notable stakeholders and the decision makers that I need to go with," he explained, "it's a 2 to 3 minute process to go through each one of these accounts." The traditional approach to AI account planning doesn't solve the territory problem. You ask ChatGPT or Claude for company information, and you get Wikipedia summaries. Founded in 1987. Headquartered in Dallas. 15,000 employees. The chief sales officer you're calling doesn't care about any of that, and showing up with generic facts makes you look lazy, not prepared. When you're new to the role, you don't have years of pattern recognition to fall back on. You don't know what good account planning looks like yet. You just know you need to get meetings with people who have better things to do than talk to a rep they've never heard of. The solution isn't using AI as a search engine. It's using it as a sales assistant with a specific job to do. The Problem With How Most Reps Use AI for Account Planning Here's what usually happens. A rep needs to prepare for a call with a VP of Marketing at a healthcare company. They open their AI tool of choice and type: "Tell me about [Company Name]." The AI spits back: Company history Product offerings Recent press releases Maybe some executive names The rep skims it, copies a few bullet points into their CRM, and calls it account planning. Then they get on the call and realize they have no idea what this VP is actually trying to accomplish this quarter. They ask surface-level questions. The prospect checks out. The meeting goes nowhere. This happens because most reps are using AI like a faster Google. They're asking for information instead of asking for intelligence. AI account planning only works when you give the AI a role and a specific outcome to deliver. Not "tell me about this company." Instead, "You're an account executive trying to book a meeting with this company's CMO in the next two weeks. Based on their recent announcements and what their executives are posting on LinkedIn, what initiatives are they likely prioritizing right now?" How to Set Up AI Agents for Account Planning The difference between a basic AI chat and an AI agent is memory and context. When you create an agent, you're teaching it what kind of output you need every single time. You're not starting from scratch with every account. Here's the framework that works: Step 1: Give Your AI Agent a Clear Role Don't just ask questions. Set up the scenario with urgency and context. For example: "You are an account executive at [Your Company]. You've been tasked with bringing in [Target Company] as a new customer within the next 90 days. Your first call is with their [specific role, like Chief Sales Officer]. Based on the materials I'm providing, what are the top three business initiatives this person is likely focused on right now?" This does two things. First, it forces the AI to think from your perspective instead of just summarizing data. Second, it prioritizes current, actionable information over historical background. Step 2: Feed It the Right Source Material Wikipedia summaries don't help you. But these sources do: Recent press releases about new initiatives or leadership changes LinkedIn posts from executives at the company (especially the person you're calling) Company blog posts about their strategic direction Industry news articles mentioning the company Their "About Us" or "Newsroom" page for current priorities Analyst reports or industry trend pieces relevant to their sector If you're selling to publicly traded companies, earnings call transcripts and annual reports (10-Ks) are gold mines. But most new AEs aren't calling on Fortune 500 companies. The good news is that smaller companies often share more on LinkedIn and their blogs because they're trying to build their brand. Upload PDFs or paste content directly into your AI tool. Then let it analyze the content through the lens of the role you gave it. The output will focus on strategic priorities, not corporate history. Step 3: Ask Follow-Up Questions Based on Persona If you're calling into marketing, tech, security, or customer experience, the priorities are different. Your AI agent should help you understand how company-wide initiatives affect the specific person you're talking to. After the initial analysis, ask: "How would these initiatives specifically impact the VP of Marketing's goals this quarter?" Now you have talking points that matter to the person on the other end of the call. Step 4: Validate With Human Intelligence AI gets you 80% of the way there in three minutes instead of fifteen. But you still need to cross-check. Look at LinkedIn. Check recent news. If you have access to account managers or customer success reps who work with similar companies, ask them if the trends you're seeing match reality. AI account planning is a tool, not a replacement for critical thinking. If the output feels off, it probably is. Trust your gut and adjust. How to Turn Research Into Value Messages The goal of account planning isn't to memorize facts about a company. It's to walk into a conversation with an informed hypothesis about what they're trying to accomplish. When you do this right, your opening changes. Instead of starting cold with "Tell me about your role," you can say: "I saw your CEO recently posted about accelerating your digital customer experience, and I'm assuming that's putting some pressure on your team to modernize how you're approaching customer engagement. But I could be completely wrong. What's actually taking up most of your time right now?" Here's how you've impacted your prospect: First, it proves you did real research. Second, it gives the prospect something specific to react to instead of making them explain their entire world from scratch. Third, and this is critical, it still leaves room for discovery. You're not skipping the "What are your biggest challenges?" question. You're earning the right to ask them by showing you've already thought about their business. When prospects talk about their challenges in their own language, you learn how they frame problems, what matters to them, and where your solution might actually fit. Even if your hypothesis is wrong, you've separated yourself from the 90% of reps who show up with nothing. And when you're right, you skip past the surface-level conversation and get straight into the dialogue that matters. That's how you earn credibility as a new account executive, even when you don't have ten years of experience to lean on. Building a Repeatable AI Account Planning Workflow This only scales if you systematize it. You can't rely on remembering the perfect prompt every time or recreating your process from scratch for every account. Create separate agents for different use cases. One for account planning. One for prospecting outreach. One for call preparation. Train each agent for the output you need so you aren't constantly course-correcting. Save your account plans in a central location. The information changes, so plan to refresh your research quarterly. What mattered in Q2 might not matter in Q4, and your account planning needs to reflect that. The key is building a system that you can repeat across your entire territory without burning out. Two to three minutes per account. Not fifteen. Not thirty. That's how you research 50 accounts in a week instead of just five. What This Actually Looks Like in Practice Let's say you're targeting a mid-market software company. You start by checking their LinkedIn. The CEO posted last week about expanding into healthcare verticals. You pull up their blog and find three recent posts about compliance challenges in healthcare tech. You upload screenshots or copy the text into your AI agent and give it the prompt: "You're an AE trying to close this software company in 90 days. The first meeting is with their Chief Revenue Officer. What are the top three priorities they're likely focused on, and how do those connect to the company's broader goals?" The AI analyzes the content and tells you: They're investing heavily in healthcare vertical expansion, but facing longer sales cycles due to compliance requirements They're dealing with the need to build credibility fast in a regulated industry Their CEO has committed to proving ROI in healthcare within two quarters Now you have a hypothesis. The CRO is probably under pressure to close healthcare deals faster while managing a team that doesn't have deep healthcare expertise. That's your angle. You cross-check this with LinkedIn and see that the CRO has been engaging with posts about sales enablement in complex verticals. You look at recent news and find they just hired a VP of Healthcare Sales. Everything lines up. Your outreach message writes itself. You're not pitching. You're acknowledging what they're working on and offering a perspective on how companies in similar situations have approached the same problem. What to Do After the Meeting Your AI workflow doesn't end when the call does. This is where most reps leave value on the table. After your meeting, take the transcript from your call recording tool (Fathom, Gong, Chorus, whatever you use) and upload it to your AI agent. Then ask specific questions:

"This is our annual Thanksgiving show. Thanksgiving is celebrated in many counties other than the United States. We will tell you the list and and how the people celebrate. Plus play songs about Thanksgiving food."

Dr. Linda Duska and Dr. Kathleen Moore discuss key studies in the evolving controversy over radical upfront surgery versus neoadjuvant chemotherapy in advanced ovarian cancer. TRANSCRIPT Dr. Linda Duska: Hello, and welcome to the ASCO Daily News Podcast. I am your guest host, Dr. Linda Duska. I am a professor of obstetrics and gynecology at the University of Virginia School of Medicine.  On today's episode, we will explore the management of advanced ovarian cancer, specifically with respect to a question that has really stirred some controversy over time, going all the way back more than 20 years: Should we be doing radical upfront surgery in advanced ovarian cancer, or should we be doing neoadjuvant chemotherapy? So, there was a lot of hype about the TRUST study, also called ENGOT ov33/AGO-OVAR OP7, a Phase 3 randomized study that compares upfront surgery with neoadjuvant chemotherapy followed by interval surgery. So, I want to talk about that study today. And joining me for the discussion is Dr. Kathleen Moore, a professor also of obstetrics and gynecology at the University of Oklahoma and the deputy director of the Stephenson Cancer Center, also at the University of Oklahoma Health Sciences.  Dr. Moore, it is so great to be speaking with you today. Thanks for doing this. Dr. Kathleen Moore: Yeah, it's fun to be here. This is going to be fun. Dr. Linda Duska: FYI for our listeners, both of our full disclosures are available in the transcript of this episode.  So let's just jump right in. We already alluded to the fact that the TRUST study addresses a question we have been grappling with in our field. Here's the thing, we have four prior randomized trials on this exact same topic. So, share with me why we needed another one and what maybe was different about this one? Dr. Kathleen Moore: That is, I think, the key question. So we have to level-set kind of our history. Let's start with, why is this even a question? Like, why are we even talking about this today? When we are taking care of a patient with newly diagnosed ovarian cancer, the aim of surgery in advanced ovarian cancer ideally is to prolong a patient's likelihood of disease-free survival, or if you want to use the term "remission," you can use the term "remission." And I think we can all agree that our objective is to improve overall survival in a way that also does not compromise her quality of life through surgical complications, which can have a big effect. The standard for many decades, certainly my entire career, which is now over 20 years, has been to pursue what we call primary cytoreductive surgery, meaning you get a diagnosis and we go right to the operating room with a goal of achieving what we call "no gross residual." That is very different – in the olden days, you would say "optimal" and get down to some predefined small amount of tumor. Now, the goal is you remove everything you can see.  The alternative strategy to that is neoadjuvant chemotherapy followed by interval cytoreductive surgery, and that has been the, quote-unquote, "safer" route because you chemically cytoreduce the cancer, and so, the resulting surgery, I will tell you, is not necessarily easy at all. It can still be very radical surgeries, but they tend to be less radical, less need for bowel resections, splenectomy, radical procedures, and in a short-term look, would be considered safer from a postoperative consideration. Dr. Linda Duska: Well, and also maybe more likely to be successful, right? Because there's less disease, maybe, theoretically. Dr. Kathleen Moore: More likely to be successful in getting to no gross residual. Dr. Linda Duska: Right. Yeah, exactly. Dr. Kathleen Moore: I agree with that. And so, so if the end game, regardless of timing, is you get to no gross residual and you help a patient and there's no difference in overall survival, then it's a no-brainer. We would not be having this conversation. But there remains a question around, while it may be more likely to get to no gross residual, it may be, and I think we can all agree, a less radical, safer surgery, do you lose survival in the long term by this approach? This has become an increasing concern because of the increase in rates of use of neoadjuvant, not only in this country, but abroad. And so, you mentioned the four prior studies. We will not be able to go through them completely. Dr. Linda Duska: Let's talk about the two modern ones, the two from 2020 because neither one of them showed a difference in overall survival, which I think we can agree is, at the end of the day, yes, PFS would be great, but OS is what we're looking for. Dr. Kathleen Moore: OS is definitely what we're looking for. I do think a marked improvement in PFS, like a real prolongation in disease-free survival, for me would be also enough. A modest improvement does not really cut it, but if you are really, really prolonging PFS, you should see that-  Dr. Linda Duska: -manifest in OS. Dr. Kathleen Moore: Yeah, yeah. Okay. So let's talk about the two modern ones. The older ones are EORTC and CHORUS, which I think we've talked about. The two more modern ones are SCORPION and JCOG0602. So, SCORPION was interesting. SCORPION was a very small study, though. So one could say it's underpowered. 170 patients. And they looked at only patients that were incredibly high risk. So, they had to have a Fagotti score, I believe, of over 9, but they were not looking at just low volume disease. Like, those patients were not enrolled in SCORPION. It was patients where you really were questioning, "Should I go to the OR or should I do neoadjuvant? Like, what's the better thing?" It is easy when it's low volume. You're like, "We're going." These were the patients who were like, "Hm, you know, what should I do?" High volume. Patients were young, about 55. The criticism of the older studies, there are many criticisms, but one of them is that, the criticism that is lobbied is that they did not really try. Whatever surgery you got, they did not really try with median operative times of 180 minutes for primary cytoreduction, 120 for neoadjuvant. Like, you and I both know, if you're in a big primary debulking, you're there all day. It's 6 hours. Dr. Linda Duska: Right, and there was no quality control for those studies, either. Dr. Kathleen Moore: No quality control. So, SCORPION, they went 451-minute median for surgery. Like, they really went for it versus four hours and then 253 for the interval, 4 hours. They really went for it on both arms. Complete gross resection was achieved in 50% of the primary cytoreduced. So even though they went for it with these very long surgeries, they only got to the goal half the time. It was almost 80% in the interval group. So they were more successful there. And there was absolutely no difference in PFS or OS. They were right about 15 months PFS, right about 40 months OS.  JCOG0602, of course, done in Japan, a big study, 300 patients, a little bit older population. Surprisingly more stage IV disease in this study than were in SCORPION. SCORPION did not have a lot of stage IV, despite being very bulky tumors. So a third of patients were stage IV. They also had relatively shorter operative times, I would say, 240 minutes for primary, 302 for interval. So still kind of short. Complete gross resection was not achieved very often. 30% of primary cytoreduction. That is not acceptable. Dr. Linda Duska: Well, so let's talk about TRUST. What was different about TRUST? Why was this an important study for us to see? Dr. Kathleen Moore: So the criticism of all of these, and I am not trying to throw shade at anyone, but the criticism of all of these is if you are putting surgery to the test, you are putting the surgeon to the test. And you are assuming that all surgeons are trained equally and are willing to do what it takes to get someone to no gross residual. Dr. Linda Duska: And are in a center that can support the post-op care for those patients. Dr. Kathleen Moore: Which can be ICU care, prolonged time. Absolutely. So when you just open these broadly, you're assuming everyone has the surgical skills and is comfortable doing that and has backup. Everybody has an ICU. Everyone has a blood bank, and you are willing to do that. And that assumption could be wrong. And so what TRUST said is, "Okay, we are only going to open this at centers that have shown they can achieve a certain level of primary cytoreduction to no gross residual disease." And so there was quality criteria. It was based on – it was mostly a European study – so ESGO criteria were used to only allow certified centers to participate. They had to have a surgical volume of over 36 cytoreductive surgeries per year. So you could not be a low volume surgeon. Your complete resection rates that were reported had to be greater than 50% in the upfront setting. I told you on the JCOG, it was 30%. Dr. Linda Duska: Right. So these were the best of the best. This was the best possible surgical situation you could put these patients in, right? Dr. Kathleen Moore: Absolutely. And you support all the things so you could mitigate postoperative complications as well. Dr. Linda Duska: So we are asking the question now again in the ideal situation, right? Dr. Kathleen Moore: Right. Dr. Linda Duska: Which, we can talk about, may or may not be generalizable to real life, but that's a separate issue because we certainly don't have those conditions everywhere where people get cared for with ovarian cancer. But how would you interpret the results of this study? Did it show us anything different? Dr. Kathleen Moore: I am going to say how we should interpret it and then what I am thinking about. It is a negative study. It was designed to show improvement in overall survival in these ideal settings in patients with FIGO stage IIIB and C, they excluded A, these low volume tumors that should absolutely be getting surgery. So FIGO stage IIIB and C and IVA and B that were fit enough to undergo radical surgery randomized to primary cytoreduction or neoadjuvant with interval, and were all given the correct chemo. Dr. Linda Duska: And they were allowed bevacizumab and PARP, also. They could have bevacizumab and PARP. Dr. Kathleen Moore: They were allowed bevacizumab and PARP. Not many of them got PARP, but it was distributed equally, so that would not be a confounder. And so that was important. Overall survival is the endpoint. It was a big study. You know, it was almost 600 patients. So appropriately powered. So let's look at what they reported. When they looked at the patients who were enrolled, this is a large study, almost 600 patients, 345 in the primary cytoreductive arm and 343 in the neoadjuvant arm. Complete resection in these patients was 70% in the primary cytoreductive arm and 85% in the neoadjuvant arm. So in both arms, it was very high. So your selection of site and surgeon worked. You got people to their optimal outcome. So that is very different than any other study that has been reported to date. But what we saw when we looked at overall survival was no statistical difference. The median was, and I know we do not like to talk about medians, but the median in the primary cytoreductive arm was 54 months versus 48 months in the neoadjuvant arm with a hazard ratio of 0.89 and, of course, the confidence interval crossed one. So this is not statistically significant. And that was the primary endpoint. Dr. Linda Duska: I know you are getting to this. They did look at PFS, and that was statistically significant, but to your point about what are we looking for for a reasonable PFS difference? It was about two months difference. When I think about this study, and I know you are coming to this, what I thought was most interesting about this trial, besides the fact that the OS, the primary endpoint was negative, was the subgroup analyses that they did. And, of course, these are hypothesis-generating only. But if you look at, for example, specifically only the stage III group, that group did seem to potentially, again, hypothesis generating, but they did seem to benefit from upfront surgery.  And then one other thing that I want to touch on before we run out of time is, do we think it matters if the patient is BRCA germline positive? Do we think it matters if there is something in particular about that patient from a biomarker standpoint that is different? I am hopeful that more data will be coming out of this study that will help inform this. Of course, unpowered, hypothesis-generating only, but it's just really interesting. What do you think of their subset analysis? Dr. Kathleen Moore: Yeah, I think the subsets are what we are going to be talking about, but we have to emphasize that this was a negative trial as designed. Dr. Linda Duska: Absolutely. Yes. Dr. Kathleen Moore: So we cannot be apologists and be like, "But this or that." It was a negative trial as designed. Now, I am a human and a clinician, and I want what is best for my patients. So I am going to, like, go down the path of subset analyses. So if you look at the stage III tumors that got complete cytoreduction, which was 70% of the cases, your PFS was almost 28 months versus 21.8 months. Dr. Linda Duska: Yes, it becomes more significant. Dr. Kathleen Moore: Yeah, that hazard ratio is 0.69. Again, it is a subset. So even though the P value here is statistically significant, it actually should not have a P value because it is an exploratory analysis. So we have to be very careful. But the hazard ratio is 0.69. So the hypothesis is in this setting, if you're stage III and you go for it and you get someone to no gross residual versus an interval cytoreduction, you could potentially have a 31% reduction in the rate of progression for that patient who got primary cytoreduction. And you see a similar trend in the stage III patients, if you look at overall survival, although the post-progression survival is so long, it's a little bit narrow of a margin.  But I do think there are some nuggets here that, one of our colleagues who is really one of the experts in surgical studies, Dr. Mario Leitao, posted this on X, and I think it really resonated after this because we were all saying, "But what about the subsets?" He is like, "It's a negative study." But at the end of the day, you are going to sit with your patient. The patient should be seen by a GYN oncologist or surgical oncologist with specialty in cytoreduction and a medical oncologist, you know, if that person does not give chemo, and the decision should be made about what to do for that individual patient in that setting. Dr. Linda Duska: Agreed. And along those lines, if you look carefully at their data, the patients who had an upfront cytoreduction had almost twice the risk of having a stoma than the patients who had an interval cytoreduction. And they also had a higher risk of needing to have a bowel resection. The numbers were small, but still, when you look at the surgical complications, as you've already said, they're higher in the upfront group than they are in the interval group. That needs to be taken into account as well when counseling a patient, right? When you have a patient in front of you who says to you, "Dr. Moore, you can take out whatever you want, but whatever you do, don't make me a bag." As long as the patient understands what that means and what they're asking us to do, I think that we need to think about that. Dr. Kathleen Moore: I think that is a great point. And I have definitely seen in our practice, patients who say, "I absolutely would not want an ostomy. It's a nonstarter for me." And we do make different decisions. And you have to just say, "That's the decision we've made," and you kind of move on, and you can't look back and say, "Well, I wish I would have, could have, should have done something else." That is what the patient wants. Ultimately, that patient, her family, autonomous beings, they need to be fully counseled, and you need to counsel that patient as to the site that you are in, her volume of disease, and what you think you can achieve. In my opinion, a patient with stage III cancer who you have the site and the capabilities to get to no gross residual should go to the OR first. That is what I believe. I do not anymore think that for stage IV. I think that this is pretty convincing to me that that is probably a harmful thing. However, I want you to react to this. I think I am going to be a little unpopular in saying this, but for me, one of the biggest take-homes from TRUST was that whether or not, and we can talk about the subsets and the stage III looked better, and I think it did, but both groups did really well. Like, really well. And these were patients with large volume disease. This was not cherry-picked small volume stage IIIs that you could have done an optimal just by doing a hysterectomy. You know, these were patients that needed radical surgery. And both did well. And so what it speaks to me is that anytime you are going to operate on someone with ovary, whether it be frontline, whether it be a primary or interval, you need a high-volume surgeon. That is what I think this means to me. Like, I would want high volume surgeon at a center that could do these surgeries, getting that patient, my family member, me, to no gross residual. That is important. And you and I are both in training centers. I think we ought to take a really strong look at, are we preparing people to do the surgeries that are necessary to get someone to no gross residual 70% and 85% of the time? Dr. Linda Duska: We are going to run out of time, but I want to address that and ask you a provocative question. So, I completely agree with what you said, that surgery is important. But I also think one of the reasons these patients in this study did so well is because all of the incredible new therapies that we have for patients. Because OS is not just about surgery. It is about surgery, but it is also about all of the amazing new therapies we have that you and others have helped us to get through clinical research. And so, how much of that do you think, like, for example, if you look at the PFS and OS rates from CHORUS and EORTC, I get it that they're, that they're not the same. It's different patients, different populations, can't do cross-trial comparisons. But the OS, as you said, in this study was 54 months and 48 months, which is, compared to 2010, we're doing much, much better. It is not just the surgery, it is also all the amazing treatment options we have for these patients, including PARP, including MIRV, including lots of other new therapies. How do you fit that into thinking about all of this? Dr. Kathleen Moore: I do think we are seeing, and we know this just from epidemiologic data that the prevalence of ovarian cancer in many of the countries where the study was done is increasing, despite a decrease in incidence. And why is that? Because people are living longer. Dr. Linda Duska: People are living longer, yeah. Dr. Kathleen Moore: Which is phenomenal. That is what we want. And we do have, I think, better supportive care now. PARP inhibitors in the frontline, which not many of these patients had. Now some of them, this is mainly in Europe, will have gotten them in the first maintenance setting, and I do think that impacts outcome. We do not have that data yet, you know, to kind of see what, I would be really interested to see. We do not do this well because in ovarian cancer, post-progression survival can be so long, we do not do well of tracking what people get when they come off a clinical trial to see how that could impact – you know, how many of them got another surgery? How many of them got a PARP? I think this group probably missed the ADC wave for the most part, because this, mirvetuximab is just very recently available in Europe. Dr. Linda Duska: Unless they were on trial. Dr. Kathleen Moore: Unless they were on trial. But I mean, I think we will have to see. 600 patients, I would bet a lot of them missed the ADC wave. So, I do not know that we can say we know what drove these phenomenal – these are some of the best curves we've seen outside of BRCA. And then coming back to your point about the BRCA population here, that is a really critical question that I do not know that we're ever going to answer. There have been hypotheses around a tumor that is driven by BRCA, if you surgically cytoreduced it, and then chemically cytoreduced it with chemo, and so you're starting PARP with nothing visible and likely still homogeneous clones. Is that the group we cured? And then if you give chemo first before surgery, it allows more rapid development of heterogeneity and more clonal evolution that those are patients who are less likely to be cured, even if they do get cytoreduced to nothing at interval with use of PARP inhibitor in the front line. That is a question that many have brought up as something we would like to understand better. Like, if you are BRCA, should you always just go for it or not? I do not know that we're ever going to really get to that. We are trying to look at some of the other studies and just see if you got neoadjuvant and you had BRCA, was anyone cured? I think that is a question on SOLO1 I would like to know the answer to, and I don't yet, that may help us get to that. But that's sort of something we do think about. You should have a fair number of them in TRUST. It wasn't a stratification factor, as I remember. Dr. Linda Duska: No, it wasn't. They stratified by center, age, and ECOG status Dr. Kathleen Moore: So you would hope with randomization that you would have an equal number in each arm. And they may be able to pull that out and do a very exploratory look. But I would be interested to see just completely hypothesis-generating what this looks like for the patients with BRCA, and I hope that they will present that. I know they're busy at work. They have translational work. They have a lot pending with TRUST. It's an incredibly rich resource that I think is going to teach us a lot, and I am excited to see what they do next. Dr. Linda Duska: So, outside of TRUST, we are out of time. I just want to give you a moment if there were any other messages that you want to share with our listeners before we wrap up. Dr. Kathleen Moore: It's an exciting time to be in GYN oncology. For so long, it was just chemo, and then the PARP inhibitors nudged us along quite a bit. We did move more patients, I believe, to the cure fraction. When we ultimately see OS, I think we'll be able to say that definitively, and that is exciting. But, you know, that is the minority of our patients. And while HRD positive benefits tremendously from PARP, I am not as sure we've moved as many to the cure fraction. Time will tell. But 50% of our patients have these tumors that are less HRD. They have a worse prognosis. I think we can say that and recur more quickly. And so the advent of these antibody-drug conjugates, and we could name 20 of them in development in GYN right now, targeting tumor-associated antigens because we're not really driven by mutations other than BRCA. We do not have a lot of things to come after. We're not lung cancer. We are not breast cancer. But we do have a lot of proteins on the surface of our cancers, and we are finally able to leverage that with some very active regimens. And we're in the early phases, I would say, of really understanding how best to use those, how best to position them, and which one to select for whom in a setting where there is going to be obvious overlap of the targets. So we're going to be really working this problem. It is a good problem. A lot of drugs that work pretty well. How do you individualize for a patient, the patient in front of you with three different markers? How do you optimize it? Where do you put them to really prolong survival? And then we finally have cell surface. We saw at ASCO, CDK2 come into play here for the first time, we've got a cell cycle inhibitor. We've been working on WEE1 and ATR for a long time. CDK2s may hit. Response rates were respectable in a resistant population that was cyclin E overexpressing. We've been working on that biomarker for a long time with a toxicity profile that was surprisingly clean, which I like to see for our patients. So that is a different platform. I think we have got bispecifics on the rise. So there is a pipeline of things behind the ADCs, which is important because we need more than one thing, that makes me feel like in the future, I am probably not going to be using doxil ever for platinum-resistant disease. So, I am going to be excited to retire some of those things. We will say, "Remember when we used to use doxil for platinum-resistant disease?" Dr. Linda Duska: I will be retired by then, but thanks for that thought. Dr. Kathleen Moore: I will remind you. Dr. Linda Duska: You are right. It is such an incredibly exciting time to be taking care of ovarian cancer patients with all the opportunities.  And I want to thank you for sharing your valuable insights with us on this podcast today and for your great work to advance care for patients with GYN cancers. Dr. Kathleen Moore: Likewise. Thanks for having me. Dr. Linda Duska: And thank you to our listeners for your time today. You will find links to the TRUST study and other studies discussed today in the transcript of this episode. Finally, if you value the insights that you hear on the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. More on today's speakers:   Dr. Linda Duska  @Lduska Dr. Kathleen Moore Follow ASCO on social media:     @ASCO on X (formerly Twitter) ASCO on Bluesky   ASCO on Facebook     ASCO on LinkedIn     Disclosures of Potential Conflicts of Interest:    Dr. Linda Duska:   Consulting or Advisory Role: Regeneron, Inovio Pharmaceuticals, Merck, Ellipses Pharma  Research Funding (Inst.): GlaxoSmithKline, Millenium, Bristol-Myers Squibb, Aeterna Zentaris, Novartis, Abbvie, Tesaro, Cerulean Pharma, Aduro Biotech, Advaxis, Ludwig Institute for Cancer Research, Leap Therapeutics  Patents, Royalties, Other Intellectual Property: UptToDate, Editor, British Journal of Ob/Gyn  Dr. Kathleen Moore: Leadership: GOG Partners, NRG Ovarian Committee Chair Honoraria: Astellas Medivation, Clearity Foundation, IDEOlogy Health, Medscape, Great Debates and Updates, OncLive/MJH Life Sciences, MD Outlook, Curio Science, Plexus, University of Florida, University of Arkansas for Medical Sciences, Congress Chanel, BIOPHARM, CEA/CCO, Physician Education Resource (PER), Research to Practice, Med Learning Group, Peerview, Peerview, PeerVoice, CME Outfitters, Virtual Incision Consulting/Advisory Role: Genentech/Roche, Immunogen, AstraZeneca, Merck, Eisai, Verastem/Pharmacyclics, AADi, Caris Life Sciences, Iovance Biotherapeutics, Janssen Oncology, Regeneron, zentalis, Daiichi Sankyo Europe GmbH, BioNTech SE, Immunocore, Seagen, Takeda Science Foundation, Zymeworks, Profound Bio, ADC Therapeutics, Third Arc, Loxo/Lilly, Bristol Myers Squibb Foundation, Tango Therapeutics, Abbvie, T Knife, F Hoffman La Roche, Tubulis GmbH, Clovis Oncology, Kivu, Genmab/Seagen, Kivu, Genmab/Seagen, Whitehawk, OnCusp Therapeutics, Natera, BeiGene, Karyopharm Therapeutics, Day One Biopharmaceuticals, Debiopharm Group, Foundation Medicine, Novocure Research Funding (Inst.): Mersana, GSK/Tesaro, Duality Biologics, Mersana, GSK/Tesaro, Duality Biologics, Merck, Regeneron, Verasatem, AstraZeneca, Immunogen, Daiichi Sankyo/Lilly, Immunocore, Torl Biotherapeutics, Allarity Therapeutics, IDEAYA Biosciences, Zymeworks, Schrodinger Other Relationship (Inst.): GOG Partners

Bookwaves/Artwaves is produced and hosted by Richard Wolinsky. Links to assorted local theater & book venues   Francine Prose: Reflections on 1974 and the Pentagon Papers Francine Prose, author of “1974, A Personal History” in conversation with host Richard Wolinsky. The author of twenty novels and ten books of non fiction, Francine Prose is best known for such novels as “Lovers at the Chameleon Club, 1932,” “The Vixen,” “Household Saints” and “Mister Monkey,” and non-fiction such as “Anne Frank: The Book, the Life, The Afterlife,” Francine Prose has also written two short story collections , and a picture book. Two of her novels have become films, and one, “The Glorious Ones,” became a Broadway musical. In this book, she recalls her time hanging out with Anthony Russo, who along with Daniel Ellsberg, was responsible for The Pentagon Papers, in San Francisco in 1974 and then a few months later, in New York, capturing the vibe of what it was like to live in that time and place, and differences between then and now. Complete Interview.   Wes Craven (1939-2015): Master of Horror Movies. Wes Craven (1939-2015), noted director of horror and genre films, interviewed by Richard Wolinsky and Richard A. Lupoff on October 13, 1999 while on tour for his one novel, “Fountain Society.” Wes Craven, who died at the age of 76 on August 30, 2015, was considered one of the masters of cinema's horror genre. Best known for The Nightmare on Elm Street and Scream films, ,He was best known for two series of films, the Nightmare on Elm Street films, and the Scream series, which also served as an academic deconstruction of the genre. Starting life as a humanities professor, Wes Craven moved over to film as first a sound editor, and then film editor before turning to writing and directing with The Last House on the Left. Along with the first Nightmare film (and the deconstruction last New Nightmare entry), he directed all four Scream films, along with Red Eye, Cursed, The Serpent and the Rainbow, and the non-genre Meryl Streep vehicle, Music of the Heart. His first and only novel, “Fountain Society,” was published in 1999, and it was during his book tour that he stopped by KPFA where he was interviewed by Richard Wolinsky and Richard A. Lupoff. That interview was digitized and re-edited in 2017 by Richard Wolinsky. Complete interview       Book Interview/Events and Theatre Links Note: Shows may unexpectedly close early or be postponed due to actors' positive COVID tests. Check the venue for closures, ticket refunds, and mask requirements before arrival. Dates are in-theater performances unless otherwise noted. Some venues operate Tuesday – Sunday; others for shorter periods each week. All times Pacific Time. Closing dates are sometimes extended. Book Stores Bay Area Book Festival  See website for highlights from the 110th Annual Bay Area Book Festival, May 31 – June 1, 2025. Book Passage.  Monthly Calendar. Mix of on-line and in-store events. Books Inc.  Mix of on-line and in-store events. The Booksmith.  Monthly Event Calendar. BookShop West Portal. Monthly Event Calendar. Center for Literary Arts, San Jose. See website for Book Club guests in upcoming months. Green Apple Books. Events calendar. Kepler's Books  On-line Refresh the Page program listings. Live Theater Companies Actors Ensemble of Berkeley.  See website for readings and events. Actor's Reading Collective (ARC).  Mary Jane by Amy Herzog, directed by Amy Kossow, November 6 – 30, Magic Theatre, Fort Mason. African American Art & Culture Complex. See website for calendar. American Conservatory Theatre  Stereophonic (in association with BroadwaySF, at the Curran), Oct 28 – Nov 23. Awesome Theatre Company. See website for information. Berkeley Playhouse. Annie. November 7- December 21. Once, February 20 – March 22.  Berkeley Rep. The Hills of California .by Jez Butterworth, Oct. 31 – Dec. 7, Roda Theatre. Mother of Exiles by Jessica Huang, World Premiere, Nov. 14 – Dec. 32, Peets Theatre. Berkeley Shakespeare Company See website for upcoming productions. Brava Theatre Center: See calendar for events listings. BroadwaySF: Stereophonic (in association with ACT), Oct 28 – Nov 23, Curran. See website for complete listings for the Orpheum, Golden Gate and Curran Theaters. Broadway San Jose:  Kinky Boots, Nov. 28-30. See website for other events. Center REP: The Woman in Black, U.S. Tour, November 5-23.. Central Stage. See website for upcoming productions, 5221 Central Avenue, Richmond Central Works See website for information on the 2026 season. Cinnabar Theatre. Young Rep: Disney's The Little Mermaid, November 14-23, Studio Space, Petaluma Outlet Mall. Club Fugazi. Dear San Francisco ongoing. Check website for Music Mondays listings. Contra Costa Civic Theatre Ebenezer Scrooge, an adaptation of “A Christmas Carol” by Joel Roster, December 6 –  21. . See website for other events. Golden Thread  See website for upcoming productions. Hillbarn Theatre: Rogers & Hammerstein's Cinderella, December 4 – 28. Lorraine Hansberry Theatre. Soulful Christmas, December 19-21, Magic Theatre. Los Altos Stage Company. A Christmas Carol, November  28 – December 21.. Lower Bottom Playaz  August Wilson's King Hedley II, November 8 -30. BAM House, Oakland. Magic Theatre. Actors Reading Collective: Mary Jane by Amy Herzog, directed by Amy Kossow, November 6 – 30, See website for other events and productions. Marin Shakespeare Company: See website for events and productions. Marin Theatre: Sally and Tom by Suzan-Lori Parks. October 30 – November 23. The Lightning Thief, MSC Teen Company, November 7 -9. Mission Cultural Center for Latino Arts Upcoming Events Page. New Conservatory Theatre Center (NCTC)  Spanish Stew by Marga Gomez, October 17 – November 23. New Performance Traditions.  See website for upcoming schedule Oakland Theater Project. Cabaret, November 21 – December 14. Odd Salon: Upcoming events in San Francisco & New York, and streaming. Palace of Fine Arts Theater.  See website for event listings. Pear Theater. Ada & The Engine  by Lauren Gunderson, November 21 – December 7. See website for staged readings and other events. Playful People Productions. See website for upcoming productions. Presidio Theatre. Peter Pan Panto, Nov. 29 – Dec. 28. See website for complete schedule of events and performances. Ray of Light: Mean Girls. May 2026. Ross Valley Players: See website for New Works Sunday night readings and other events. San Francisco Playhouse. Into the Woods. November 30 – January 17, 2026. SFBATCO.  See website for upcoming streaming and in- theater shows. San Jose Stage Company: See website for events and upcoming season Shotgun Players.  Sunday in the Park with George, November 15 – December 30. South Bay Musical Theatre:  Let It Snow: A Broadway Holiday Celebration, December 20-21, Little Women, The Broadway Musical, January 24 – February 14, 2026. SPARC: See website for upcoming events. Stagebridge: See website for events and productions. Storytime every 4th Saturday. The Breath Project. Streaming archive. The Marsh: Calendar listings for Berkeley, San Francisco and Marshstream. Theatre Lunatico  See website for upcoming productions.. Theatre Rhino  The Break-Up written and performed by Tina D'Elia, November 6-23. Streaming: Essential Services Project, conceived and performed by John Fisher, all weekly performances now available on demand. TheatreWorks Silicon Valley. A Driving Beat by Jordan Ramirez Puckett, Oct 29 – Nov. 23, . Mountain View Center for the Performing Arts Second Stage.Georgiana & Kitty, Christmas at Pemberley by Lauren Gunderson and Margot Melcon, Dec. 3 – 28, Lucie Stern Theatre. Word for Word.  See website for upcoming productions. Misc. Listings: BAMPFA: On View calendar for Berkeley Art Museum and Pacific Film Archive. Berkeley Symphony: See website for listings. Chamber Music San Francisco: Calendar, 2025 Season. Dance Mission Theatre. On stage events calendar. Fort Mason Center. Events calendar. Oregon Shakespeare Festival: Calendar listings and upcoming shows. San Francisco Gay Men's Chorus. See schedule for upcoming SFGMC performances. San Francisco Opera. Calendar listings. San Francisco Symphony. Calendar listings. Filmed Live Musicals: Searchable database of all filmed live musicals, podcast, blog. If you'd like to add your bookstore or theater venue to this list, please write Richard@kpfa.org   . The post November 20, 2025: Francine Prose – Wes Craven appeared first on KPFA.

11/19/25: Young@Heart Chorus' Bob Cilman, Orlando Isaza & Caroline McDonald: “Ten-Alarm Fire: We Will Not Shut Up!” Ellsberg Initiative's Chris Appy and Farai Chidea: “How to Read America.” Community Action's Energy Program Dir Peter Wingate: staying warm. “Between The Mountain and the Sky” with filmmakers Larry Hott & Jeremy Power Regimbal and the protagonist, Nepal-based Maggie Doyne.

The 697th of a series of weekly radio programmes created by :zoviet*france: First broadcast 15 November 2025 by Resonance 104.4 FM and CJMP 90.1 FM Thanks to the artists, sound designer and sound recordist included here for their fine work. track list 00 [anonymous] - Intro 01 Embers Below Zero - Spring Dusk 02 Edø Pisto Sømi - 3 State Steady 03 Anton Lambert & Thanos Polymeneas Liontiris - The One 04 Breaking Light - Nothing to Hide So Nothing to Fear 05 Ray Cobley - Dreaming of Insects 06 Monosounds - Dusty – 808 – 03 – F 07 Baaskat - Sup M8 08 George Brecht & George Maciunas with James Tenney - Entrance... (Excerpt) 09 acs272 - World's 'Longest-Echo' 3rd Impulse 10 [unknown sound designer / BBC] - Futuristic – Weapons – Stun Gun (Single Burst) 11 Shaun Robert - Apartamento en el centro 12 Pablo Diserens - Melt Morphemes (Supraglacial) 13 Julie Berry / SE Trains - stb_asi 14 [unknown sound recordist / BBC] - Cars – Peugeot – 1.9 Litre (Diesel) 1986/87 Model: Exterior: Approach from Left, Skid, Idle, Switch Off 15 99Sounds - Rain-Umbrella-04 16 Michael Snow - Amitabha Chenden Kala performed by Monks of the Kagyupa Sect, Bhutan 17 Yea Big, Jon Byler Dann, and Tatsuya Nakatani - Fever One ++ [anonymous] - Outro

Our newly adopted mission statement reflects our core values of justice and compassion, which represent our public and private commitments to Christ-like acts of mercy. These values are rooted in the ancient wisdom of scripture, including teachings from Hebrew prophets and the life and witness of Jesus. This Sunday, we continue to focus on our congregation's mission and how the new community described by Isaiah invites each of us to be part of this community and its "Chorus of Generosity." www.TheLoftLA.org

After Gandalf retold the tale of his imprisonment by Saruman, he told Del that the dwarves suspected that Grungus had sold them out and used the ring to get the dragon's treasures for himself, so they headed to the brothel to question Grungus directly. Adam and Guy also went there looking for Grungus, but arrived shortly after the others to find the hobbit had been stabbed to death. Meanwhile, Tyler convinced Yolo to trust him, and Yolo revealed that Grungus had stabbed a small riddle-obsessed creature in cold blood to steal the ring. Is there any hope of deducing who murdered a person with endless grudges against him?***Del's character played by Tom this episode while she's out sick***Featuring players Tyler Hewitt, Del Borovic, Guy Bradford, and Adam McNamara, and Dungeon Master Tom McGee.Jesters of Middle-earth streams live every Wednesday at 7:30pm ET on Twitch (https://www.twitch.tv/dumbdumbdice)Enjoying Jesters of Middle-earth? - Consider supporting the show for as little as $1 a month to get BTS fun, an ad-free feed, and even add your own character to the podcast! (https://dumbdumbdice.com/join)- Buy merch on our website (https://dumbdumbdice.com/)- Follow us on social media: @dumbdumbdice- Watch our video episodes on YouTube (https://youtube.com/@dumbdumbdice) Artwork by the brilliant Del Borovic- Website & Portfolio (https://delborovic.com/), @deltastic on socialsTheme song by Sound Gallery by Dmitry Taras- YouTube (https://www.youtube.com/@soundgallerybydmitrytaras)- Pixabay (https://pixabay.com/music/fantasy-dreamy-childrens-dark-mysterious-halloween-night-scary-creepy-spooky-horror-music-116551/)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"Video may have killed the radio star but streaming and individual choices in music killed the video. Paramount Global has begun shutting down Mtv channels in Europe and reports are that soon it will come to the United States. Mtv is 44 and it looks like it may not make it to 45. "

Host: Coach Guests: Center Stage Quartet Air date: Nov 13, 2025

Bookwaves/Artwaves is produced and hosted by Richard Wolinsky. Links to assorted local theater & book venues   Amy Bloom: Award-Winning Literary Novelist, 2007 Amy Bloom, award-winning novelist and short-story writer, in conversation with Richard Wolinsky in the KPFA studios, on October 4, 2007 while on tour for her second novel, “Away.” Amy Bloom, says the New Yorker, gets more meaning into individual sentences than most authors manage in whole books. The author of five short story collections and two works of non-fiction, including a memoir, she has only written five novels since she debuted in 1997 with Love Invents Us.  She would be interviewed again on Bookwaves for her third novel, Lucky Us,  Her most recent novel, I'll Be Right Here, was published in June 2025.     John Banville: Irish Literary Master John Banville, Booker Prize winning novelist, in conversation with host Richard Wolinsky in the KPFA studios, on March 19, 2007 while on tour for the novel, “Christine Falls,” written under the pseudonym Benjamin Black. John Banville is a giant of Irish literature, winner of the Booker Prize for his novel, The Sea, and the Franz Kafka Prize in 2011. A literary novelist of the first order, he took a turn in 2007 with a mystery novel, Christine Falls, featuring a detective named Quirke, under the pseudonym Benjamin Black. Since that time there have been ten Quirke mysteries, three written under his own name, and four novels under the pseudonym. He continues to write literary and noir fiction. His most recent novel is “Venetian Vespers,” published in October, 2025.   Review of “A Driving Beat” at TheatreWorks Mountain View Center for the Performing Arts Second Stage, through November 23, 2025.   Review of “Sally and Tom” at Marin Theatre through November 23, 2025   Book Interview/Events and Theatre Links Note: Shows may unexpectedly close early or be postponed due to actors' positive COVID tests. Check the venue for closures, ticket refunds, and mask requirements before arrival. Dates are in-theater performances unless otherwise noted. Some venues operate Tuesday – Sunday; others for shorter periods each week. All times Pacific Time. Closing dates are sometimes extended. Book Stores Bay Area Book Festival  See website for highlights from the 110th Annual Bay Area Book Festival, May 31 – June 1, 2025. Book Passage.  Monthly Calendar. Mix of on-line and in-store events. Books Inc.  Mix of on-line and in-store events. The Booksmith.  Monthly Event Calendar. BookShop West Portal. Monthly Event Calendar. Center for Literary Arts, San Jose. See website for Book Club guests in upcoming months. Green Apple Books. Events calendar. Kepler's Books  On-line Refresh the Page program listings. Live Theater Companies Actors Ensemble of Berkeley.  See website for readings and events. Actor's Reading Collective (ARC).  Mary Jane by Amy Herzog, directed by Amy Kossow, November 6 – 30, Magic Theatre, Fort Mason. African American Art & Culture Complex. See website for calendar. American Conservatory Theatre  Stereophonic (in association with BroadwaySF, at the Curran), Oct 28 – Nov 23. Awesome Theatre Company. See website for information. Berkeley Playhouse. Annie. November 7- December 21. Once, February 20 – March 22.  Berkeley Rep. The Hills of California .by Jez Butterworth, Oct. 31 – Dec. 7, Roda Theatre. Mother of Exiles by Jessica Huang, World Premiere, Nov. 14 – Dec. 32, Peets Theatre. Berkeley Shakespeare Company See website for upcoming productions. Brava Theatre Center: See calendar for events listings. BroadwaySF: Stereophonic (in association with ACT), Oct 28 – Nov 23, Curran. See website for complete listings for the Orpheum, Golden Gate and Curran Theaters. Broadway San Jose:  Kinky Boots, Nov. 28-30. See website for other events. Center REP: The Woman in Black, U.S. Tour, November 5-23.. Central Stage. See website for upcoming productions, 5221 Central Avenue, Richmond Central Works Dada Teen Musical: The Play by Maury Zeff, Oct. 18 – Nov. 16, Cinnabar Theatre. Young Rep: Disney's The Little Mermaid, November 14-23, Studio Space, Petaluma Outlet Mall. Club Fugazi. Dear San Francisco ongoing. Check website for Music Mondays listings. Contra Costa Civic Theatre Ebenezer Scrooge, an adaptation of “A Christmas Carol” by Joel Roster, December 6 –  21. . See website for other events. Golden Thread  See website for upcoming productions. Hillbarn Theatre: Rogers & Hammerstein's Cinderella, December 4 – 28. Lorraine Hansberry Theatre. Soulful Christmas, December 19-21, Magic Theatre. Los Altos Stage Company. A Christmas Carol, November  28 – December 21.. Lower Bottom Playaz  August Wilson's King Hedley II, November 8 -30. BAM House, Oakland. Magic Theatre. Actors Reading Collective: Mary Jane by Amy Herzog, directed by Amy Kossow, November 6 – 30, See website for other events and productions. Marin Shakespeare Company: See website for events and productions. Marin Theatre: Sally and Tom by Suzan-Lori Parks. October 30 – November 23. The Lightning Thief, MSC Teen Company, November 7 -9. Mission Cultural Center for Latino Arts Upcoming Events Page. New Conservatory Theatre Center (NCTC)  Spanish Stew by Marga Gomez, October 17 – November 23. New Performance Traditions.  See website for upcoming schedule Oakland Theater Project. Cabaret, November 21 – December 14. Odd Salon: Upcoming events in San Francisco & New York, and streaming. Palace of Fine Arts Theater.  See website for event listings. Pear Theater. Ada & The Engine  by Lauren Gunderson, November 21 – December 7. See website for staged readings and other events. Playful People Productions. Newsies, November 8-16. Presidio Theatre. Peter Pan Panto, Nov. 29 – Dec. 28. See website for complete schedule of events and performances. Ray of Light: Mean Girls. May 2026. Ross Valley Players: See website for New Works Sunday night readings and other events. San Francisco Playhouse. Into the Woods. November 30 – January 17, 2026. SFBATCO.  See website for upcoming streaming and in- theater shows. San Jose Stage Company: See website for events and upcoming season Shotgun Players.  Sunday in the Park with George, November 15 – December 30. South Bay Musical Theatre:  Let It Snow: A Broadway Holiday Celebration, December 20-21, Little Women, The Broadway Musical, January 24 – February 14, 2026. SPARC: See website for upcoming events. Stagebridge: See website for events and productions. Storytime every 4th Saturday. The Breath Project. Streaming archive. The Marsh: Calendar listings for Berkeley, San Francisco and Marshstream. Theatre Lunatico Frankenstein, October 11 – November 2. Theatre Rhino  The Break-Up written and performed by Tina D'Elia, November 6-23. Streaming: Essential Services Project, conceived and performed by John Fisher, all weekly performances now available on demand. TheatreWorks Silicon Valley. A Driving Beat by Jordan Ramirez Puckett, Oct 29 – Nov. 23, . Mountain View Center for the Performing Arts Second Stage.Georgiana & Kitty, Christmas at Pemberley by Lauren Gunderson and Margot Melcon, Dec. 3 – 28, Lucie Stern Theatre. Word for Word.  See website for upcoming productions. Misc. Listings: BAMPFA: On View calendar for Berkeley Art Museum and Pacific Film Archive. Berkeley Symphony: See website for listings. Chamber Music San Francisco: Calendar, 2025 Season. Dance Mission Theatre. On stage events calendar. Fort Mason Center. Events calendar. Oregon Shakespeare Festival: Calendar listings and upcoming shows. San Francisco Gay Men's Chorus. See schedule for upcoming SFGMC performances. San Francisco Opera. Calendar listings. San Francisco Symphony. Calendar listings. Filmed Live Musicals: Searchable database of all filmed live musicals, podcast, blog. If you'd like to add your bookstore or theater venue to this list, please write Richard@kpfa.org   . The post November 13, 2025: Amy Bloom – John Banville appeared first on KPFA.

Welcome to the Christmas series! Amid defeat, oppression, and captivity, a prophetic chorus of hope was uttered from the darkness. The message to the hurting and broken is this: a hero is coming!  Sign up for special devotionals at StoriesoftheMessiah.com. As we dive deeply into iconic Bible heroes' enthralling narratives, we find more than just stories of faith and miracles. We discover a recurrent theme, a spiritual undertone that connects each tale to the grandeur of the Gospel. They're not just standalone legends; they're threads in a divine tapestry, weaving a story that foreshadows Jesus Christ, the ultimate hero, the promised Messiah who brings light to the darkest corners of history. For more Bible stories download the Pray.com app.  To learn more about Rabbi Schneider visit https://discoveringthejewishjesus.com/ See omnystudio.com/listener for privacy information.

Pella All-State Chorus Students Malachi Van Haaften, Abbie Brand, Joeley Helle, Chase Swenson, and Riley Black discuss the November 20-22 festival. The band will be featured on Thursday.

Live your life like it's choir practice. John Witnessed... 1. The Coming of the Completion v.1 2. The Choir of the Conquerors v.2 3. The Chorus of the King v.3-4   - God is right in all of His ways The Saints celebrate... The Unrivaled Nature of His Character The Universal Nature of His Salvation The Unblemished Nature of His Acts  

Summary Season 4 launches with a field guide to American cults: where they came from, how they function, and what sets them apart from orthodox Christianity. We lay out our two-episode rhythm for each movement (history + doctrine) and explain why this isn't just academic—these are the folks knocking on your door and sitting in your break room. Highlights Walter Martin's working definition of a cult The 1830–1890 surge in the Northeast and the “Burned-Over District” First vs. Second Great Awakening—and how Finney's “new measures” influenced later errors Doctrinal markers: denial of the Trinity, diminished view of Christ, extra-biblical revelation Sociological markers: authoritarian leadership, information control, us-vs-them identity, behavioral rules, shunning, apocalyptic urgency Works/loyalty systems vs. the gospel of grace The real cost of leaving—and how Christians can care well Connect Website & Blog: www.chorusinthechaos.com Facebook: https://www.facebook.com/chorusinthec... Instagram: https://www.instagram.com/chorus_in_the_chaos/ Twitter: https://twitter.com/Chorusnthechaos Intro/Outro Music (by our good friend Nick Illes): https://open.spotify.com/artist/7tnsQ... Email: chorusinthechaos@email.com Generations Be sure to visit our friends at Generations.org! They've built an incredible library of Christ-centered homeschool curriculum, books, and podcasts — all designed to help your family apply the Bible to every area of life. History, science, worldview, you name it — it all points back to Christ. Use the code CHORUS at checkout for 15% off your order.

The worthiness and worship of Jesus in John's vision reaches a climactic point as the whole of Creation joins in the worship.Here's the link for today's Takeaway Question: https://www.youtube.com/watch?v=vCcGqMHndxo

Everybody sing it with us…. ELIZABETH TAYLOR! Today, Sara and Laura are analyzing the second track from The Life Of A Showgirl, which has quickly become one of their absolute favorites! After discussing their Eras Tour Documentary “Wi$hli$t,” the ladies analyze the song's lyrics to explore Taylor's connection to the famously beautiful and notoriously scandalous icon, Elizabeth Taylor. Musso & Frank's menu has Sara and Laura dreaming of a Swiftie field trip to Hollywood, and after listening to this episode, you'll be wanting one too! Chapters(00:00) Welcome & Introduction(00:55) What's On Our Plates(10:54) Taylor Updates(17:33) Our Eras Tour Documentary Wi$hli$t(30:41) Analyzing 'Elizabeth Taylor' Track(34:16) Folk"lore" of the Song(42:44) Intro: Asking A Muse, But Also Herself(45:13)Verse 1: Portofino Honeymoons, The Pressure Of Fame & Relationships, Past Relationships Withering Away(52:46) Chorus 1: Elizabeth's Violet Eyes, Anxiety and Paranoia, Partnership Desires(59:55) Verse 2: Gifts for Someone Like Taylor, Elizabeth's Jewelry Collection, Musso & Frank's(01:06:24) Bridge: Perfume, Ex Lovers Will Always Be Tied To Taylor(01:09:35) Chorus 3 & Outro: Max Martin Adlibs(01:11:18) Music Theory Production Notes(01:12:49) Favorite Lyrics & Rating(01:14:04) This Song As A Recipe(01:19:40) Signing Off!SUPPORT US ON PATREON! Show us some love and get monthly bonus episodes and first dibs on upcoming episode ideas. We'd be enchanted to have you join our Swiftie community!Links ReferencedTaylor Swift's Otter T-Shirt Inspires Fundraiser with Over $2.2 Million Donated to Sea AnimalsTaylor Swift Donates $100K to Toddler Fighting Brain Cancer: 'Sending the Biggest Hug'Ruby Rose Slams ‘Incredibly Stupid' Criticism of Taylor Swift's ‘Trad Wife' Lyrics on ‘Showgirl': ‘Stop It'Taylor Swift Just Revealed the Inspo Behind Her Song “Elizabeth Taylor” and It's So, So SweetA Guide to the Old Hollywood Restaurant in Taylor Swift's ‘Elizabeth Taylor'Old Saint Nick's Chocolate Espresso MartiniPlease make sure to subscribe and leave a review. If you'd like to reach out to send in a question or comment, please do so via any of these platforms:email blankplatepod@gmail.comleave a voicemail at (717) 382-831Patreon (get bonus episodes and first dibs on episode ideas)YouTubeInstagramTikTokYou can also follow Sara and Laura individually:• Laura: Instagram and Tiktok• Sara: InstagramListen to our previous podcast: Passports & Pizza

"At least three record companies have extended million dollar contracts to people who create AI music. The US Copyright office has said it will begin extending protection those who use AI as a tool. The PROs will extend licensing. We will tell you what is going on."

The gentle tinkling of cowbells in a field among the Dolomites at the end of a long summer afternoon. Recorded in Colmean, Italy by Cities and Memory, June 2025.